Response to anti-PD1/PDL1 therapy in patients with metastatic desmoplastic melanoma.

被引:0
|
作者
Eroglu, Zeynep
Kim, Dae Won
Johnson, Douglas Buckner
Algazi, Alain Patrick
Munhoz, Rodrigo Ramella
Liniker, Elizabeth
Kong, Ben
Khurana, Neharika
Chmielowski, Bartosz
Sosman, Jeffrey Alan
Scolyer, Richard A.
Carlino, Matteo S.
Postow, Michael Andrew
Hwu, Wen-Jen
Long, Georgina V.
Ribas, Antoni
机构
[1] City Hope Natl Med Ctr, Pasadena, CA USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Vanderbilt Univ, Nashville, TN 37235 USA
[4] Univ Calif San Francisco, San Francisco, CA 94143 USA
[5] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[6] Melanoma Inst Australia, Sydney, NSW, Australia
[7] Westmead Canc Ctr, Strathfield, NSW, Australia
[8] UC San Francisco, San Francisco, CA USA
[9] Univ Calif Los Angeles, Los Angeles, CA USA
[10] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[11] Univ Sydney, Melanoma Inst Australia, Royal Prince Alfred Hosp, Sydney, NSW 2006, Australia
[12] Westmead Hosp, Baulkham Hills, Australia
[13] Melanoma Inst Australia, Sydney, NSW, Australia
[14] Univ Sydney, Sydney, NSW, Australia
[15] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
9011
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Anti-PD1/PDL1 induced psoriasis
    Voudouri, D.
    Nikolaou, V.
    Laschos, K.
    Charpidou, A.
    Soupos, N.
    Triantafyllopoulou, I.
    Panoutsopoulou, I.
    Tsimpoukis, S.
    Aravantinos, G.
    Syrigos, K.
    Stratigos, A. J.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 : 53 - 54
  • [2] Anti-PD1/PDL1 induced psoriasis
    Voudouri, Dimitra
    Nikolaou, Vasiliki
    Laschos, Konstantinos
    Charpidou, Andriani
    Soupos, Nikolaos
    Triantafyllopoulou, Ioanna
    Panoutsopoulou, Ioanna
    Aravantinos, Gerasimos
    Syrigos, K.
    Stratigos, A.
    [J]. CURRENT PROBLEMS IN CANCER, 2017, 41 (06) : 407 - 412
  • [3] TILs and Anti-PD1 Therapy: An Alternative Combination Therapy for PDL1 Negative Metastatic Cervical Cancer
    Yin, Huanhuan
    Guo, Wei
    Sun, Xiangling
    Li, Ruili
    Feng, Cuihua
    Tan, Yujie
    [J]. JOURNAL OF IMMUNOLOGY RESEARCH, 2020, 2020
  • [4] Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
    Lei, Qingyang
    Wang, Dan
    Sun, Kai
    Wang, Liping
    Zhang, Yi
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [5] Predicting the response to anti-PD1 therapy in metastatic melanoma
    Heinzerling, Lucie
    Kirchberger, Michael Constantin
    Walter, Lisa
    Schuler, Gerold
    [J]. TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S576 - S579
  • [6] Germline biomarkers predict toxicity to anti-PD1/PDL1 checkpoint therapy
    Weidhaas, Joanne
    Marco, Nicholas
    Scheffler, Aaron W.
    Kalbasi, Anusha
    Wilenius, Kirk
    Rietdorf, Emily
    Gill, Jaya
    Heilig, Mara
    Desler, Caroline
    Chin, Robert K.
    Kaprealian, Tania
    McCloskey, Susan
    Raldow, Ann
    Raja, Naga P.
    Kesari, Santosh
    Carrillo, Jose
    Drakaki, Alexandra
    Scholz, Mark
    Telesca, Donatello
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (02)
  • [7] Clinical analysis of patients (pts) with lung cancer treated with anti-PD1/PDL1 therapy
    Zhao, Xin
    Liu, Siyao
    Su, Junyan
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [8] Distribution of anti-PD1/PDL1 autoantibodies in multiple cancer types and potential biomarker role for anti-PD1 therapy
    Tan, Q.
    Wang, Y.
    Liu, S.
    Luo, R.
    Wang, S.
    Liang, T.
    Yang, J.
    Xing, P.
    Yao, J.
    Wu, D.
    Zhang, Z.
    Dai, J.
    Yu, X.
    Han, X.
    Shi, Y.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1097 - S1098
  • [9] Why anti-PD1/PDL1 therapy is so effective? Another piece in the puzzle
    Marchetti, Antonio
    Di Lorito, Alessia
    Buttitta, Fiamma
    [J]. JOURNAL OF THORACIC DISEASE, 2017, 9 (12) : 4863 - 4866
  • [10] Clinical analysis of patients (pts) with Lung cancer treated with anti-PD1/PDL1 therapy.
    Tian, Kaihua
    Wang, Xintong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)